We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Equinor
EQNR
$96.5B
| $13.1M | 0.11% |
+905,416
| New | +$12.7M |
|
|
VISN
277
Vistance Networks Inc
VISN
$2.56B
| $13.1M | 0.11% |
1,569,700
+1,509,269
| +2,498% | +$14.9M |
|
278
Williams Companies
WMB
$86.6B
| $13M | 0.11% |
686,036
-1,397,003
| -67% | -$26M |
|
279
Dana Inc
DAN
$3.2B
| $12.9M | 0.11% |
1,058,864
-153,619
| -13% | -$1.67M |
|
280
Blackrock
BLK
$176B
| $12.9M | 0.11% |
23,638
-42,005
| -64% | -$21.2M |
|
|
MTOR
281
DELISTED
MERITOR, Inc.
MTOR
| $12.8M | 0.11% |
648,571
+47,558
| +8% | +$879K |
|
282
Nokia
NOK
$51.4B
| $12.7M | 0.11% |
2,891,135
+138,051
| +5% | +$522K |
|
283
Waters Corp
WAT
$40.4B
| $12.7M | 0.11% |
70,516
+35,702
| +103% | +$6.75M |
|
|
SWAV
284
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $12.7M | 0.11% |
268,489
+31,042
| +13% | +$1.28M |
|
285
Axalta
AXTA
$8.06B
| $12.7M | 0.11% |
+563,011
| New | +$11.5M |
|
286
ArcelorMittal
MT
$56B
| $12.6M | 0.11% |
1,177,204
+501,698
| +74% | +$5.06M |
|
287
Schneider National
SNDR
$6.24B
| $12.6M | 0.11% |
+511,551
| New | +$11.3M |
|
|
SFIX
288
Stitch Fix
SFIX
$544M
| $12.5M | 0.11% |
+500,729
| New | +$9.88M |
|
289
Kennametal
KMT
$2.43B
| $12.4M | 0.11% |
431,060
+385,766
| +852% | +$9.83M |
|
290
PUT
Align Technology
ALGN
$12.4B
| $12.3M | 0.11% |
+45,000
| New | +$10.1M |
|
291
CALL
BioMarin Pharmaceuticals
BMRN
$12.7B
| $12.3M | 0.11% |
+100,000
| New | +$9.94M |
|
292
Cogent Communications
CCOI
$510M
| $12.3M | 0.11% |
+159,260
| New | +$12.9M |
|
293
Monster Beverage
MNST
$90.1B
| $12.3M | 0.11% |
+355,106
| New | +$11.6M |
|
294
Bio-Rad Laboratories Class A
BIO
$9.35B
| $12.2M | 0.11% |
+27,082
| New | +$12M |
|
295
EastGroup Properties
EGP
$10.8B
| $12.1M | 0.1% |
101,680
+57,087
| +128% | +$6.31M |
|
296
Skyworks Solutions
SWKS
$10.4B
| $12M | 0.1% |
+93,853
| New | +$10.4M |
|
297
Humana
HUM
$46.6B
| $12M | 0.1% |
+30,899
| New | +$11.6M |
|
298
Perrigo
PRGO
$1.73B
| $11.8M | 0.1% |
213,743
-186,679
| -47% | -$9.83M |
|
|
SCHW
299
CALL
Charles Schwab
SCHW
$190B
| $11.8M | 0.1% |
350,000
-52,500
| -13% | -$1.88M |
|
300
Rapid7
RPD
$763M
| $11.8M | 0.1% |
+231,012
| New | +$10.8M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.